6.55
price up icon15.32%   0.87
after-market アフターアワーズ: 6.57 0.02 +0.31%
loading
前日終値:
$5.68
開ける:
$5.87
24時間の取引高:
257.39K
Relative Volume:
3.99
時価総額:
$99.64M
収益:
-
当期純損益:
-
株価収益率:
-9.2358
EPS:
-0.7092
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+31.00%
1か月 パフォーマンス:
+70.36%
6か月 パフォーマンス:
+122.79%
1年 パフォーマンス:
+309.37%
1日の値動き範囲:
Value
$5.85
$7.00
1週間の範囲:
Value
$4.8305
$7.00
52週間の値動き範囲:
Value
$1.001
$7.00

Alterity Therapeutics Ltd Adr Stock (ATHE) Company Profile

Name
名前
Alterity Therapeutics Ltd Adr
Name
セクター
Healthcare (1164)
Name
電話
-
Name
住所
-
Name
職員
10
Name
Twitter
@AlterityT
Name
次回の収益日
2024-08-29
Name
最新のSEC提出書
Name
ATHE's Discussions on Twitter

ATHE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ATHE
Alterity Therapeutics Ltd Adr
6.55 84.08M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Alterity Therapeutics Ltd Adr Stock (ATHE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-03 ダウングレード The Benchmark Company Speculative Buy → Hold
2024-12-12 開始されました Maxim Group Buy

Alterity Therapeutics Ltd Adr (ATHE) 最新ニュース

pulisher
Jul 14, 2025

SMCI’s Market Flip-Flop: Exploring the Volatility of 2025 Performance - investchronicle.com

Jul 14, 2025
pulisher
Jun 23, 2025

Alterity CEO to provide corporate update on ATH434 development By Investing.com - Investing.com India

Jun 23, 2025
pulisher
May 12, 2025

Alterity Therapeutics highlighted at MSA Congress - Investing.com

May 12, 2025
pulisher
May 12, 2025

Alterity Therapeutics highlighted at MSA Congress By Investing.com - Investing.com India

May 12, 2025
pulisher
May 07, 2025

Alterity Therapeutics reports Phase 2 data at MSA Congress - Investing.com

May 07, 2025
pulisher
May 07, 2025

Alterity Therapeutics reports Phase 2 data at MSA Congress By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
Apr 10, 2025

Alterity shares new phase 2 data on MSA treatment - Investing.com

Apr 10, 2025
pulisher
Apr 07, 2025

Alterity Therapeutics announces regulatory notice - Investing.com

Apr 07, 2025
pulisher
Apr 07, 2025

Alterity Therapeutics completes placement - Investing.com

Apr 07, 2025
pulisher
Apr 07, 2025

Alterity Therapeutics announces regulatory notice By Investing.com - Investing.com UK

Apr 07, 2025
pulisher
Apr 07, 2025

Alterity Therapeutics completes placement By Investing.com - Investing.com UK

Apr 07, 2025
pulisher
Mar 27, 2025

ATHEAlterity Therapeutics Ltd Latest Stock News & Market Updates - Stock Titan

Mar 27, 2025
pulisher
Mar 27, 2025

Alterity Concludes Open-Label Trial Patient Visits - Investing.com

Mar 27, 2025
pulisher
Feb 18, 2025

Alterity Therapeutics announces compliance notice - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Alterity Therapeutics Issues Over 1 Billion New Shares - TipRanks

Feb 18, 2025
pulisher
Feb 13, 2025

Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight - GlobeNewswire Inc.

Feb 13, 2025
pulisher
Feb 10, 2025

Alterity Therapeutics raises A$40M in placement - TipRanks

Feb 10, 2025
pulisher
Feb 10, 2025

Alterity secures funding to advance MSA drug development - Investing.com India

Feb 10, 2025
pulisher
Feb 06, 2025

JPMorgan Ceases Substantial Holding in Alterity Therapeutics - TipRanks

Feb 06, 2025
pulisher
Feb 06, 2025

Alterity Therapeutics announces trading halt - Investing.com

Feb 06, 2025
pulisher
Feb 05, 2025

Alterity Therapeutics Initiates Trading Halt for Capital Raising Announcement - TipRanks

Feb 05, 2025
pulisher
Feb 05, 2025

JPMorgan Becomes Substantial Holder in Alterity Therapeutics - TipRanks

Feb 05, 2025
pulisher
Feb 05, 2025

Alterity Therapeutics reports compliance with Takeovers Panel By Investing.com - Investing.com South Africa

Feb 05, 2025
pulisher
Feb 05, 2025

Alterity Therapeutics reports compliance with Takeovers Panel - Investing.com

Feb 05, 2025
pulisher
Feb 04, 2025

Alterity Therapeutics Discloses Equity Derivative Positions of Point72 - TipRanks

Feb 04, 2025
pulisher
Feb 04, 2025

Alterity Therapeutics announces securities notice - Investing.com

Feb 04, 2025
pulisher
Feb 03, 2025

Alterity Therapeutics Completes Significant Share Issuance - TipRanks

Feb 03, 2025
pulisher
Feb 03, 2025

Alterity Therapeutics Quotes Over 164 Million Securities on ASX - TipRanks

Feb 03, 2025
pulisher
Feb 03, 2025

Alterity Therapeutics announces ATH434 Phase 2 trial results - MSN

Feb 03, 2025
pulisher
Feb 02, 2025

Alterity Therapeutics Announces Major Securities Placement - TipRanks

Feb 02, 2025
pulisher
Feb 02, 2025

Alterity Therapeutics Secures Funding to Advance Neurodegenerative Drug Development - TipRanks

Feb 02, 2025
pulisher
Jan 29, 2025

Alterity Therapeutics Reports Promising Phase 2 Results for MSA Drug ATH434 - TipRanks

Jan 29, 2025
pulisher
Jan 27, 2025

Alterity Therapeutics Initiates Trading Halt Pending Phase II Trial Results - TipRanks

Jan 27, 2025
pulisher
Jan 25, 2025

Predictive Oncology Inc (NASDAQ: POAI) Stock Is A Good Option To Consider - Stocks Register

Jan 25, 2025
pulisher
Jan 24, 2025

Alterity Therapeutics reports quarterly activities - Investing.com

Jan 24, 2025
pulisher
Jan 23, 2025

Alterity Therapeutics Advances ATH434 Clinical Trials with Promising Data - TipRanks

Jan 23, 2025
pulisher
Jan 22, 2025

Alterity Therapeutics Expands ASX Quoted Securities - TipRanks

Jan 22, 2025
pulisher
Jan 21, 2025

Alterity Therapeutics Reports Key Advances and Anticipates Milestones in 2025 - TipRanks

Jan 21, 2025
pulisher
Jan 16, 2025

Alterity Therapeutics Highlights Key Milestones in Neurodegenerative Disease Pipeline - TipRanks

Jan 16, 2025
pulisher
Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024
pulisher
Dec 16, 2024

Most active stocks: US stocks with the highest trading volume today - Yahoo

Dec 16, 2024
pulisher
Dec 04, 2024

ASX November Health Winners: Paradigm, Imricor lead sector as momentum returns - Stockhead

Dec 04, 2024
pulisher
Mar 06, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 06, 2024
pulisher
Feb 15, 2024

Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners - Stockhead

Feb 15, 2024
pulisher
Aug 17, 2023

Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money ... - Stockhead

Aug 17, 2023
pulisher
Aug 03, 2023

Biotech Stocks: Longevity Company Stocks - Investing.com

Aug 03, 2023
pulisher
Jan 06, 2023

Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation) - PR Newswire

Jan 06, 2023
pulisher
Jan 10, 2022

Alterity Therapeutics LtdADR Shares Close the Week 40.3% HigherWeekly Wrap - Nasdaq

Jan 10, 2022
pulisher
Jan 30, 2019

Most Volatile Stocks, What Investors Need to Know - MarketBeat

Jan 30, 2019

Alterity Therapeutics Ltd Adr (ATHE) 財務データ

Alterity Therapeutics Ltd Adr (ATHE) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):